MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from maturities
of investments
$149,500K
Net cash provided by
(used in) investing...
$66,100K
Canceled cashflow
$83,400K
Net increase in
cash, cash...
$1,686K
Canceled cashflow
$64,414K
Purchases of investments
$81,731K
Purchases of property and
equipment
$1,669K
Stock-based compensation
expense
$14,720K
Accounts payable
$1,536K
Depreciation expense
$1,356K
Non-cash operating lease
expense
$1,027K
Prepaid expenses and
other current assets
-$190K
Other assets
-$137K
Proceeds from exercise of
stock options
$1K
Net cash used in
operating activities
-$63,665K
Net cash (used in)
provided by financing...
-$749K
Canceled cashflow
$18,966K
Canceled cashflow
$1K
Net loss
-$77,905K
Payments of tax
withholdings related to...
$750K
Accrued expenses and
other liabilities
-$3,353K
Operating lease
liabilities
-$936K
Net amortization of
premiums and accretion of...
$437K
Back
Back
Cash Flow
source: myfinsight.com
Acrivon Therapeutics, Inc. (ACRV)
Acrivon Therapeutics, Inc. (ACRV)